vs
Side-by-side financial comparison of ASTRAZENECA PLC (AZN) and JBS N.V. (JBS). Click either name above to swap in a different company.
JBS N.V. is the larger business by last-quarter revenue ($22.6B vs $14.5B, roughly 1.6× ASTRAZENECA PLC). ASTRAZENECA PLC runs the higher net margin — 16.9% vs 2.9%, a 14.1% gap on every dollar of revenue. On growth, JBS N.V. posted the faster year-over-year revenue change (13.4% vs 11.7%).
AstraZeneca plc (AZ) is a Swedish-British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
JBS N.V. is a Brazilian multinational company that is the largest meat processing enterprise in the world, producing factory processed beef, chicken, salmon, sheep, pork, and also selling by-products from the processing of these meats. It is headquartered in São Paulo. It was founded in 1953 in Anápolis, Goiás.
AZN vs JBS — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $14.5B | $22.6B |
| Net Profit | $2.4B | $644.1M |
| Gross Margin | 82.9% | 13.2% |
| Operating Margin | 24.3% | 5.4% |
| Net Margin | 16.9% | 2.9% |
| Revenue YoY | 11.7% | 13.4% |
| Net Profit YoY | 27.0% | -14.9% |
| EPS (diluted) | $1.57 | $0.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $22.6B | ||
| Q2 25 | $14.5B | — | ||
| Q3 24 | — | $19.9B | ||
| Q2 24 | $12.9B | — | ||
| Q2 23 | $11.4B | — | ||
| Q2 22 | $10.8B | — |
| Q3 25 | — | $644.1M | ||
| Q2 25 | $2.4B | — | ||
| Q3 24 | — | $756.6M | ||
| Q2 24 | $1.9B | — | ||
| Q2 23 | $1.8B | — | ||
| Q2 22 | $360.0M | — |
| Q3 25 | — | 13.2% | ||
| Q2 25 | 82.9% | — | ||
| Q3 24 | — | 16.5% | ||
| Q2 24 | 83.1% | — | ||
| Q2 23 | 82.8% | — | ||
| Q2 22 | 72.2% | — |
| Q3 25 | — | 5.4% | ||
| Q2 25 | 24.3% | — | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | 21.2% | — | ||
| Q2 23 | 21.5% | — | ||
| Q2 22 | 5.0% | — |
| Q3 25 | — | 2.9% | ||
| Q2 25 | 16.9% | — | ||
| Q3 24 | — | 3.8% | ||
| Q2 24 | 14.9% | — | ||
| Q2 23 | 15.9% | — | ||
| Q2 22 | 3.3% | — |
| Q3 25 | — | $0.52 | ||
| Q2 25 | $1.57 | — | ||
| Q3 24 | — | $0.62 | ||
| Q2 24 | $1.24 | — | ||
| Q2 23 | $1.17 | — | ||
| Q2 22 | $0.23 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.1B | $485.5B |
| Total DebtLower is stronger | — | $213.0M |
| Stockholders' EquityBook value | $44.8B | $9.5B |
| Total Assets | $112.4B | $44.2B |
| Debt / EquityLower = less leverage | — | 0.02× |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $485.5B | ||
| Q2 25 | $7.1B | — | ||
| Q3 24 | — | $5.1B | ||
| Q2 24 | $6.9B | — | ||
| Q2 23 | $5.7B | — | ||
| Q2 22 | $4.8B | — |
| Q3 25 | — | $213.0M | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q3 25 | — | $9.5B | ||
| Q2 25 | $44.8B | — | ||
| Q3 24 | — | $9.5B | ||
| Q2 24 | $39.6B | — | ||
| Q2 23 | $37.4B | — | ||
| Q2 22 | $36.0B | — |
| Q3 25 | — | $44.2B | ||
| Q2 25 | $112.4B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $104.3B | — | ||
| Q2 23 | $96.5B | — | ||
| Q2 22 | $96.6B | — |
| Q3 25 | — | 0.02× | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $996.4M |
| Free Cash FlowOCF − Capex | — | $-264.6M |
| FCF MarginFCF / Revenue | — | -1.2% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | — | 1.55× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $996.4M | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q3 25 | — | $-264.6M | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q3 25 | — | -1.2% | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q3 25 | — | 5.6% | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q3 25 | — | 1.55× | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
